Teva Pharmaceutical Industries Limited (TEVA): David Einhorn Trims Holding

Teva Pharmaceutical Industries Limited (NYSE:TEVA) has featured successful the 13F portfolio of Greenlight Capital since the 4th fourth of 2023. Back then, this presumption comprised 268,000 shares. In the coming quarters, the money steadily loaded up connected the stock, expanding the involvement by 21%, 44%, and 21%. A monolithic buying enactment was registered successful the 2nd 4th of 2025 erstwhile the money accrued this holding by much than 550%. Filings for the 4th fourth of 2025 amusement that the money owns conscionable implicit 3 cardinal shares successful the pharma firm, down adjacent to 20% compared to filings for the 3rd 4th of 2025.

Teva Pharmaceutical Industries Limited (NYSE:TEVA) has been connected the radar of elite hedge funds arsenic the steadfast makes a strategical displacement toward innovative, high-margin marque drugs. The champion illustration of this is AUSTEDO, a attraction for tardive dyskinesia whose income grew importantly successful 2025 and are projected to deed $2.5 cardinal by 2027. Another catalyst for the shares is that successful the 4th fourth of 2025, for the archetypal time, Teva’s innovative brands – AUSTEDO, AJOVY, and UZEDY – collectively delivered implicit $1 cardinal successful a azygous quarter. Pipeline drugs look promising arsenic well. Teva is processing a imaginable blockbuster for inflammatory bowel disease. Recent information positions it arsenic a best-in-class therapy. Institutional involvement peaked aft a $400 cardinal backing statement with Blackstone to accelerate its development.

While we admit the imaginable of TEVA arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: Billionaire Stan Druckenmiller's 10 Small and Mid-Cap Stock Picks with Huge Upside Potential and Israel Englander Stock Portfolio: Top 10 Stock Picks.

Disclosure: None. Follow Insider Monkey connected Google News.